Fulgent Genetics Inc (FLGT)

May 30, 2025, 10:00 AM EDT - 1 day ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

May 29, 2025, 10:00 AM EDT - 2 days ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 28, 2025, 10:00 AM EDT - 3 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 4 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

May 24, 2025, 9:19 PM EDT - 7 days ago

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

May 19, 2025, 8:11 AM EDT - 12 days ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

May 2, 2025, 12:27 PM EDT - 4 weeks ago

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

May 2, 2025, 7:00 AM EDT - 4 weeks ago

Fulgent Reports First Quarter 2025 Financial Results

Apr 10, 2025, 4:05 PM EDT - 7 weeks ago

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Apr 4, 2025, 2:30 PM EDT - 2 months ago

Stock Picks From Seeking Alpha's March 2025 New Analysts

AI ARGX CCL CEPU CF CROX CUK

Mar 20, 2025, 5:46 AM EDT - 2 months ago

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Feb 28, 2025, 11:57 AM EST - 3 months ago

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 7:00 AM EST - 3 months ago

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 6, 2025, 4:05 PM EST - 4 months ago

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Feb 4, 2025, 4:00 PM EST - 4 months ago

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Dec 24, 2024, 1:25 AM EST - 5 months ago

Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside

Nov 11, 2024, 2:07 AM EST - 7 months ago

Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:00 AM EST - 7 months ago

Fulgent Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 8:00 AM EST - 7 months ago

Fulgent to Participate in Upcoming Conferences

Oct 31, 2024, 8:00 AM EDT - 7 months ago

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Oct 17, 2024, 4:05 PM EDT - 8 months ago

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Sep 25, 2024, 11:32 AM EDT - 8 months ago

Fulgent Genetics: An NCAV Pick With Profit And Growth Potential

Sep 9, 2024, 12:05 PM EDT - 9 months ago

Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Aug 2, 2024, 10:24 AM EDT - 10 months ago

Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 7:00 AM EDT - 10 months ago

Fulgent Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 4:05 PM EDT - 11 months ago

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

Jun 10, 2024, 1:00 AM EDT - 1 year ago

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

NEO

Jun 6, 2024, 11:36 AM EDT - 1 year ago

Fulgent Genetics: Growth Is Returning

Jun 3, 2024, 8:00 AM EDT - 1 year ago

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer

May 24, 2024, 8:00 AM EDT - 1 year ago

Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting

May 14, 2024, 4:05 PM EDT - 1 year ago

Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics

May 3, 2024, 11:43 AM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q1 2024 Earnings Call Transcript

May 3, 2024, 7:00 AM EDT - 1 year ago

Fulgent Reports First Quarter 2024 Financial Results

Apr 11, 2024, 4:05 PM EDT - 1 year ago

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

Feb 28, 2024, 10:59 AM EST - 1 year ago

Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 7:00 AM EST - 1 year ago

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 7:20 AM EST - 1 year ago

Fulgent Genetics: Buy Growth Ahead Below Liquidation Value

Feb 13, 2024, 8:00 AM EST - 1 year ago

Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

Feb 9, 2024, 8:31 AM EST - 1 year ago

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

COO

Nov 14, 2023, 4:30 PM EST - 1 year ago

Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 3, 2023, 4:05 PM EDT - 1 year ago

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

Nov 3, 2023, 12:22 PM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 7:00 AM EDT - 1 year ago

Fulgent Reports Third Quarter 2023 Financial Results

Oct 25, 2023, 8:00 AM EDT - 1 year ago

Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting

Oct 17, 2023, 8:00 AM EDT - 1 year ago

Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023

Sep 21, 2023, 5:06 PM EDT - 1 year ago

Fulgent Genetics: Navigating Post-COVID Growing Pains

Aug 4, 2023, 10:33 AM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q2 2023 Earnings Call Transcript